Exploring the potential possibilities to modulate gustatory coding by pharmacological manipulation remains an intriguing clinical challenge. Mojca Jensterle Sever, PhD, first study author After reviewing this study, Mir Ali, MD, a board certified bariatric surgeon and medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, CA, told MNT he found this studys findings interesting
Step 2: Provider Review & Prescription Talk with your provider to ensure your diagnosis is documented and your GLP-1 prescription is written to treat that condition
Here, we investigated the impact of acute SGLT2 inhibition on glucosuria in people with HNF1A-MODY and type 2 diabetes (T2D), respectively
The trial was overseen and sponsored by Novo Nordisk
For patients who feel hungry soon after meals or struggle with late-night cravings, this effect can be a major advantage in building healthier eating patterns